Previous Close | 11.12 |
Open | 10.95 |
Bid | 10.00 x 800 |
Ask | 10.29 x 1300 |
Day's Range | 9.81 - 11.15 |
52 Week Range | 8.23 - 34.50 |
Volume | |
Avg. Volume | 703,714 |
Market Cap | 532.262M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NEVE ILAN, Israel, May 19, 2022--Nanox Announces its First Quarter of 2022 Financial Results and Provides Business Update
NEVE ILAN, Israel, May 05, 2022--Nanox to Report First Quarter 2022 Results on May 19, 2022
NEVE ILAN, Israel, May 02, 2022--NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission ("SEC") on May 2, 2022. The annual report on Form 20-F, which contains the Company’s audited consolidated financial statements, can be accessed on the SEC’s website at www.sec.gov and on the Company